Global Dry Powder Inhaler Device Supply, Demand and Key Producers, 2026-2032

January 2026 | 125 pages | ID: GE116C215AE5EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Dry Powder Inhaler Device market size is expected to reach $ 1284 million by 2032, rising at a market growth of 4.8% CAGR during the forecast period (2026-2032).

A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.

GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, etc. are the key players in the global Dry Powder Inhaler Device market. Top 4 took up more than 30% of the global market.

From the view of region, USA have a larger consumption market share which account for about 35% of total share. Europe hold a market share of about 25%. In addition, Asia Pacific is also play important role in Global market.

Dry Powder Inhaler Device main application area is Asthma This sector hold a market share of over 80%. Then followed by the COPD.

According to the Segmentation of types, all the market of Dry Powder Inhaler Device can be divided as follows: Multi-dose, Single-dose.

This report studies the global Dry Powder Inhaler Device production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Dry Powder Inhaler Device and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Dry Powder Inhaler Device that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Dry Powder Inhaler Device total production and demand, 2021-2032, (K Units)

Global Dry Powder Inhaler Device total production value, 2021-2032, (USD Million)

Global Dry Powder Inhaler Device production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)

Global Dry Powder Inhaler Device consumption by region & country, CAGR, 2021-2032 & (K Units)

U.S. VS China: Dry Powder Inhaler Device domestic production, consumption, key domestic manufacturers and share

Global Dry Powder Inhaler Device production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)

Global Dry Powder Inhaler Device production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)

Global Dry Powder Inhaler Device production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)

This report profiles key players in the global Dry Powder Inhaler Device market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind, Mylan, Novartis, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Dry Powder Inhaler Device market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global Dry Powder Inhaler Device Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Dry Powder Inhaler Device Market, Segmentation by Type:
  • Single Dose
  • Multi Dose
Global Dry Powder Inhaler Device Market, Segmentation by Application:
  • Asthma
  • COPD
  • Others
Companies Profiled:
  • GlaxoSmithKline
  • AstraZeneca
  • Boehringer Ingelheim
  • Chiesi
  • Cipla
  • 3M
  • Hovione
  • Mannkind
  • Mylan
  • Novartis
  • Schering/Merck
  • Teva
  • Vectura
Key Questions Answered:
1. How big is the global Dry Powder Inhaler Device market?
2. What is the demand of the global Dry Powder Inhaler Device market?
3. What is the year over year growth of the global Dry Powder Inhaler Device market?
4. What is the production and production value of the global Dry Powder Inhaler Device market?
5. Who are the key producers in the global Dry Powder Inhaler Device market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Dry Powder Inhaler Device Introduction
1.2 World Dry Powder Inhaler Device Supply & Forecast
  1.2.1 World Dry Powder Inhaler Device Production Value (2021 & 2025 & 2032)
  1.2.2 World Dry Powder Inhaler Device Production (2021-2032)
  1.2.3 World Dry Powder Inhaler Device Pricing Trends (2021-2032)
1.3 World Dry Powder Inhaler Device Production by Region (Based on Production Site)
  1.3.1 World Dry Powder Inhaler Device Production Value by Region (2021-2032)
  1.3.2 World Dry Powder Inhaler Device Production by Region (2021-2032)
  1.3.3 World Dry Powder Inhaler Device Average Price by Region (2021-2032)
  1.3.4 North America Dry Powder Inhaler Device Production (2021-2032)
  1.3.5 Europe Dry Powder Inhaler Device Production (2021-2032)
  1.3.6 China Dry Powder Inhaler Device Production (2021-2032)
  1.3.7 Japan Dry Powder Inhaler Device Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Dry Powder Inhaler Device Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Dry Powder Inhaler Device Major Market Trends

2 DEMAND SUMMARY

2.1 World Dry Powder Inhaler Device Demand (2021-2032)
2.2 World Dry Powder Inhaler Device Consumption by Region
  2.2.1 World Dry Powder Inhaler Device Consumption by Region (2021-2026)
  2.2.2 World Dry Powder Inhaler Device Consumption Forecast by Region (2027-2032)
2.3 United States Dry Powder Inhaler Device Consumption (2021-2032)
2.4 China Dry Powder Inhaler Device Consumption (2021-2032)
2.5 Europe Dry Powder Inhaler Device Consumption (2021-2032)
2.6 Japan Dry Powder Inhaler Device Consumption (2021-2032)
2.7 South Korea Dry Powder Inhaler Device Consumption (2021-2032)
2.8 ASEAN Dry Powder Inhaler Device Consumption (2021-2032)
2.9 India Dry Powder Inhaler Device Consumption (2021-2032)

3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World Dry Powder Inhaler Device Production Value by Manufacturer (2021-2026)
3.2 World Dry Powder Inhaler Device Production by Manufacturer (2021-2026)
3.3 World Dry Powder Inhaler Device Average Price by Manufacturer (2021-2026)
3.4 Dry Powder Inhaler Device Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global Dry Powder Inhaler Device Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for Dry Powder Inhaler Device in 2025
  3.5.3 Global Concentration Ratios (CR8) for Dry Powder Inhaler Device in 2025
3.6 Dry Powder Inhaler Device Market: Overall Company Footprint Analysis
  3.6.1 Dry Powder Inhaler Device Market: Region Footprint
  3.6.2 Dry Powder Inhaler Device Market: Company Product Type Footprint
  3.6.3 Dry Powder Inhaler Device Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: Dry Powder Inhaler Device Production Value Comparison
  4.1.1 United States VS China: Dry Powder Inhaler Device Production Value Comparison (2021 & 2025 & 2032)
  4.1.2 United States VS China: Dry Powder Inhaler Device Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Dry Powder Inhaler Device Production Comparison
  4.2.1 United States VS China: Dry Powder Inhaler Device Production Comparison (2021 & 2025 & 2032)
  4.2.2 United States VS China: Dry Powder Inhaler Device Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Dry Powder Inhaler Device Consumption Comparison
  4.3.1 United States VS China: Dry Powder Inhaler Device Consumption Comparison (2021 & 2025 & 2032)
  4.3.2 United States VS China: Dry Powder Inhaler Device Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Dry Powder Inhaler Device Manufacturers and Market Share, 2021-2026
  4.4.1 United States Based Dry Powder Inhaler Device Manufacturers, Headquarters and Production Site (States, Country)
  4.4.2 United States Based Manufacturers Dry Powder Inhaler Device Production Value (2021-2026)
  4.4.3 United States Based Manufacturers Dry Powder Inhaler Device Production (2021-2026)
4.5 China Based Dry Powder Inhaler Device Manufacturers and Market Share
  4.5.1 China Based Dry Powder Inhaler Device Manufacturers, Headquarters and Production Site (Province, Country)
  4.5.2 China Based Manufacturers Dry Powder Inhaler Device Production Value (2021-2026)
  4.5.3 China Based Manufacturers Dry Powder Inhaler Device Production (2021-2026)
4.6 Rest of World Based Dry Powder Inhaler Device Manufacturers and Market Share, 2021-2026
  4.6.1 Rest of World Based Dry Powder Inhaler Device Manufacturers, Headquarters and Production Site (State, Country)
  4.6.2 Rest of World Based Manufacturers Dry Powder Inhaler Device Production Value (2021-2026)
  4.6.3 Rest of World Based Manufacturers Dry Powder Inhaler Device Production (2021-2026)

5 MARKET ANALYSIS BY TYPE

5.1 World Dry Powder Inhaler Device Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
  5.2.1 Single Dose
  5.2.2 Multi Dose
5.3 Market Segment by Type
  5.3.1 World Dry Powder Inhaler Device Production by Type (2021-2032)
  5.3.2 World Dry Powder Inhaler Device Production Value by Type (2021-2032)
  5.3.3 World Dry Powder Inhaler Device Average Price by Type (2021-2032)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Dry Powder Inhaler Device Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
  6.2.1 Asthma
  6.2.2 COPD
  6.2.3 Others
6.3 Market Segment by Application
  6.3.1 World Dry Powder Inhaler Device Production by Application (2021-2032)
  6.3.2 World Dry Powder Inhaler Device Production Value by Application (2021-2032)
  6.3.3 World Dry Powder Inhaler Device Average Price by Application (2021-2032)

7 COMPANY PROFILES

7.1 GlaxoSmithKline
  7.1.1 GlaxoSmithKline Details
  7.1.2 GlaxoSmithKline Major Business
  7.1.3 GlaxoSmithKline Dry Powder Inhaler Device Product and Services
  7.1.4 GlaxoSmithKline Dry Powder Inhaler Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.1.5 GlaxoSmithKline Recent Developments/Updates
  7.1.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.2 AstraZeneca
  7.2.1 AstraZeneca Details
  7.2.2 AstraZeneca Major Business
  7.2.3 AstraZeneca Dry Powder Inhaler Device Product and Services
  7.2.4 AstraZeneca Dry Powder Inhaler Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.2.5 AstraZeneca Recent Developments/Updates
  7.2.6 AstraZeneca Competitive Strengths & Weaknesses
7.3 Boehringer Ingelheim
  7.3.1 Boehringer Ingelheim Details
  7.3.2 Boehringer Ingelheim Major Business
  7.3.3 Boehringer Ingelheim Dry Powder Inhaler Device Product and Services
  7.3.4 Boehringer Ingelheim Dry Powder Inhaler Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.3.5 Boehringer Ingelheim Recent Developments/Updates
  7.3.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.4 Chiesi
  7.4.1 Chiesi Details
  7.4.2 Chiesi Major Business
  7.4.3 Chiesi Dry Powder Inhaler Device Product and Services
  7.4.4 Chiesi Dry Powder Inhaler Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.4.5 Chiesi Recent Developments/Updates
  7.4.6 Chiesi Competitive Strengths & Weaknesses
7.5 Cipla
  7.5.1 Cipla Details
  7.5.2 Cipla Major Business
  7.5.3 Cipla Dry Powder Inhaler Device Product and Services
  7.5.4 Cipla Dry Powder Inhaler Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.5.5 Cipla Recent Developments/Updates
  7.5.6 Cipla Competitive Strengths & Weaknesses
7.6 3M
  7.6.1 3M Details
  7.6.2 3M Major Business
  7.6.3 3M Dry Powder Inhaler Device Product and Services
  7.6.4 3M Dry Powder Inhaler Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.6.5 3M Recent Developments/Updates
  7.6.6 3M Competitive Strengths & Weaknesses
7.7 Hovione
  7.7.1 Hovione Details
  7.7.2 Hovione Major Business
  7.7.3 Hovione Dry Powder Inhaler Device Product and Services
  7.7.4 Hovione Dry Powder Inhaler Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.7.5 Hovione Recent Developments/Updates
  7.7.6 Hovione Competitive Strengths & Weaknesses
7.8 Mannkind
  7.8.1 Mannkind Details
  7.8.2 Mannkind Major Business
  7.8.3 Mannkind Dry Powder Inhaler Device Product and Services
  7.8.4 Mannkind Dry Powder Inhaler Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.8.5 Mannkind Recent Developments/Updates
  7.8.6 Mannkind Competitive Strengths & Weaknesses
7.9 Mylan
  7.9.1 Mylan Details
  7.9.2 Mylan Major Business
  7.9.3 Mylan Dry Powder Inhaler Device Product and Services
  7.9.4 Mylan Dry Powder Inhaler Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.9.5 Mylan Recent Developments/Updates
  7.9.6 Mylan Competitive Strengths & Weaknesses
7.10 Novartis
  7.10.1 Novartis Details
  7.10.2 Novartis Major Business
  7.10.3 Novartis Dry Powder Inhaler Device Product and Services
  7.10.4 Novartis Dry Powder Inhaler Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.10.5 Novartis Recent Developments/Updates
  7.10.6 Novartis Competitive Strengths & Weaknesses
7.11 Schering/Merck
  7.11.1 Schering/Merck Details
  7.11.2 Schering/Merck Major Business
  7.11.3 Schering/Merck Dry Powder Inhaler Device Product and Services
  7.11.4 Schering/Merck Dry Powder Inhaler Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.11.5 Schering/Merck Recent Developments/Updates
  7.11.6 Schering/Merck Competitive Strengths & Weaknesses
7.12 Teva
  7.12.1 Teva Details
  7.12.2 Teva Major Business
  7.12.3 Teva Dry Powder Inhaler Device Product and Services
  7.12.4 Teva Dry Powder Inhaler Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.12.5 Teva Recent Developments/Updates
  7.12.6 Teva Competitive Strengths & Weaknesses
7.13 Vectura
  7.13.1 Vectura Details
  7.13.2 Vectura Major Business
  7.13.3 Vectura Dry Powder Inhaler Device Product and Services
  7.13.4 Vectura Dry Powder Inhaler Device Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.13.5 Vectura Recent Developments/Updates
  7.13.6 Vectura Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Dry Powder Inhaler Device Industry Chain
8.2 Dry Powder Inhaler Device Upstream Analysis
  8.2.1 Dry Powder Inhaler Device Core Raw Materials
  8.2.2 Main Manufacturers of Dry Powder Inhaler Device Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Dry Powder Inhaler Device Production Mode
8.6 Dry Powder Inhaler Device Procurement Model
8.7 Dry Powder Inhaler Device Industry Sales Model and Sales Channels
  8.7.1 Dry Powder Inhaler Device Sales Model
  8.7.2 Dry Powder Inhaler Device Typical Distributors

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES

Table 1. World Dry Powder Inhaler Device Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Dry Powder Inhaler Device Production Value by Region (2021-2026) & (USD Million)
Table 3. World Dry Powder Inhaler Device Production Value by Region (2027-2032) & (USD Million)
Table 4. World Dry Powder Inhaler Device Production Value Market Share by Region (2021-2026)
Table 5. World Dry Powder Inhaler Device Production Value Market Share by Region (2027-2032)
Table 6. World Dry Powder Inhaler Device Production by Region (2021-2026) & (K Units)
Table 7. World Dry Powder Inhaler Device Production by Region (2027-2032) & (K Units)
Table 8. World Dry Powder Inhaler Device Production Market Share by Region (2021-2026)
Table 9. World Dry Powder Inhaler Device Production Market Share by Region (2027-2032)
Table 10. World Dry Powder Inhaler Device Average Price by Region (2021-2026) & (USD/Unit)
Table 11. World Dry Powder Inhaler Device Average Price by Region (2027-2032) & (USD/Unit)
Table 12. Dry Powder Inhaler Device Major Market Trends
Table 13. World Dry Powder Inhaler Device Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Dry Powder Inhaler Device Consumption by Region (2021-2026) & (K Units)
Table 15. World Dry Powder Inhaler Device Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Dry Powder Inhaler Device Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Dry Powder Inhaler Device Producers in 2025
Table 18. World Dry Powder Inhaler Device Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Dry Powder Inhaler Device Producers in 2025
Table 20. World Dry Powder Inhaler Device Average Price by Manufacturer (2021-2026) & (USD/Unit)
Table 21. Global Dry Powder Inhaler Device Company Evaluation Quadrant
Table 22. World Dry Powder Inhaler Device Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Dry Powder Inhaler Device Production Site of Key Manufacturer
Table 24. Dry Powder Inhaler Device Market: Company Product Type Footprint
Table 25. Dry Powder Inhaler Device Market: Company Product Application Footprint
Table 26. Dry Powder Inhaler Device Competitive Factors
Table 27. Dry Powder Inhaler Device New Entrant and Capacity Expansion Plans
Table 28. Dry Powder Inhaler Device Mergers & Acquisitions Activity
Table 29. United States VS China Dry Powder Inhaler Device Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Dry Powder Inhaler Device Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Dry Powder Inhaler Device Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Dry Powder Inhaler Device Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Dry Powder Inhaler Device Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Dry Powder Inhaler Device Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Dry Powder Inhaler Device Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Dry Powder Inhaler Device Production Market Share (2021-2026)
Table 37. China Based Dry Powder Inhaler Device Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Dry Powder Inhaler Device Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Dry Powder Inhaler Device Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Dry Powder Inhaler Device Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Dry Powder Inhaler Device Production Market Share (2021-2026)
Table 42. Rest of World Based Dry Powder Inhaler Device Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Dry Powder Inhaler Device Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Dry Powder Inhaler Device Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Dry Powder Inhaler Device Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Dry Powder Inhaler Device Production Market Share (2021-2026)
Table 47. World Dry Powder Inhaler Device Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Dry Powder Inhaler Device Production by Type (2021-2026) & (K Units)
Table 49. World Dry Powder Inhaler Device Production by Type (2027-2032) & (K Units)
Table 50. World Dry Powder Inhaler Device Production Value by Type (2021-2026) & (USD Million)
Table 51. World Dry Powder Inhaler Device Production Value by Type (2027-2032) & (USD Million)
Table 52. World Dry Powder Inhaler Device Average Price by Type (2021-2026) & (USD/Unit)
Table 53. World Dry Powder Inhaler Device Average Price by Type (2027-2032) & (USD/Unit)
Table 54. World Dry Powder Inhaler Device Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 55. World Dry Powder Inhaler Device Production by Application (2021-2026) & (K Units)
Table 56. World Dry Powder Inhaler Device Production by Application (2027-2032) & (K Units)
Table 57. World Dry Powder Inhaler Device Production Value by Application (2021-2026) & (USD Million)
Table 58. World Dry Powder Inhaler Device Production Value by Application (2027-2032) & (USD Million)
Table 59. World Dry Powder Inhaler Device Average Price by Application (2021-2026) & (USD/Unit)
Table 60. World Dry Powder Inhaler Device Average Price by Application (2027-2032) & (USD/Unit)
Table 61. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 62. GlaxoSmithKline Major Business
Table 63. GlaxoSmithKline Dry Powder Inhaler Device Product and Services
Table 64. GlaxoSmithKline Dry Powder Inhaler Device Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. GlaxoSmithKline Recent Developments/Updates
Table 66. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 67. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 68. AstraZeneca Major Business
Table 69. AstraZeneca Dry Powder Inhaler Device Product and Services
Table 70. AstraZeneca Dry Powder Inhaler Device Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. AstraZeneca Recent Developments/Updates
Table 72. AstraZeneca Competitive Strengths & Weaknesses
Table 73. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 74. Boehringer Ingelheim Major Business
Table 75. Boehringer Ingelheim Dry Powder Inhaler Device Product and Services
Table 76. Boehringer Ingelheim Dry Powder Inhaler Device Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Boehringer Ingelheim Recent Developments/Updates
Table 78. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 79. Chiesi Basic Information, Manufacturing Base and Competitors
Table 80. Chiesi Major Business
Table 81. Chiesi Dry Powder Inhaler Device Product and Services
Table 82. Chiesi Dry Powder Inhaler Device Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Chiesi Recent Developments/Updates
Table 84. Chiesi Competitive Strengths & Weaknesses
Table 85. Cipla Basic Information, Manufacturing Base and Competitors
Table 86. Cipla Major Business
Table 87. Cipla Dry Powder Inhaler Device Product and Services
Table 88. Cipla Dry Powder Inhaler Device Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Cipla Recent Developments/Updates
Table 90. Cipla Competitive Strengths & Weaknesses
Table 91. 3M Basic Information, Manufacturing Base and Competitors
Table 92. 3M Major Business
Table 93. 3M Dry Powder Inhaler Device Product and Services
Table 94. 3M Dry Powder Inhaler Device Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. 3M Recent Developments/Updates
Table 96. 3M Competitive Strengths & Weaknesses
Table 97. Hovione Basic Information, Manufacturing Base and Competitors
Table 98. Hovione Major Business
Table 99. Hovione Dry Powder Inhaler Device Product and Services
Table 100. Hovione Dry Powder Inhaler Device Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 101. Hovione Recent Developments/Updates
Table 102. Hovione Competitive Strengths & Weaknesses
Table 103. Mannkind Basic Information, Manufacturing Base and Competitors
Table 104. Mannkind Major Business
Table 105. Mannkind Dry Powder Inhaler Device Product and Services
Table 106. Mannkind Dry Powder Inhaler Device Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 107. Mannkind Recent Developments/Updates
Table 108. Mannkind Competitive Strengths & Weaknesses
Table 109. Mylan Basic Information, Manufacturing Base and Competitors
Table 110. Mylan Major Business
Table 111. Mylan Dry Powder Inhaler Device Product and Services
Table 112. Mylan Dry Powder Inhaler Device Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 113. Mylan Recent Developments/Updates
Table 114. Mylan Competitive Strengths & Weaknesses
Table 115. Novartis Basic Information, Manufacturing Base and Competitors
Table 116. Novartis Major Business
Table 117. Novartis Dry Powder Inhaler Device Product and Services
Table 118. Novartis Dry Powder Inhaler Device Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. Novartis Recent Developments/Updates
Table 120. Novartis Competitive Strengths & Weaknesses
Table 121. Schering/Merck Basic Information, Manufacturing Base and Competitors
Table 122. Schering/Merck Major Business
Table 123. Schering/Merck Dry Powder Inhaler Device Product and Services
Table 124. Schering/Merck Dry Powder Inhaler Device Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Schering/Merck Recent Developments/Updates
Table 126. Schering/Merck Competitive Strengths & Weaknesses
Table 127. Teva Basic Information, Manufacturing Base and Competitors
Table 128. Teva Major Business
Table 129. Teva Dry Powder Inhaler Device Product and Services
Table 130. Teva Dry Powder Inhaler Device Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 131. Teva Recent Developments/Updates
Table 132. Teva Competitive Strengths & Weaknesses
Table 133. Vectura Basic Information, Manufacturing Base and Competitors
Table 134. Vectura Major Business
Table 135. Vectura Dry Powder Inhaler Device Product and Services
Table 136. Vectura Dry Powder Inhaler Device Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 137. Vectura Recent Developments/Updates
Table 138. Vectura Competitive Strengths & Weaknesses
Table 139. Global Key Players of Dry Powder Inhaler Device Upstream (Raw Materials)
Table 140. Global Dry Powder Inhaler Device Typical Customers
Table 141. Dry Powder Inhaler Device Typical Distributors

LIST OF FIGURES

Figure 1. Dry Powder Inhaler Device Picture
Figure 2. World Dry Powder Inhaler Device Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Dry Powder Inhaler Device Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Dry Powder Inhaler Device Production (2021-2032) & (K Units)
Figure 5. World Dry Powder Inhaler Device Average Price (2021-2032) & (USD/Unit)
Figure 6. World Dry Powder Inhaler Device Production Value Market Share by Region (2021-2032)
Figure 7. World Dry Powder Inhaler Device Production Market Share by Region (2021-2032)
Figure 8. North America Dry Powder Inhaler Device Production (2021-2032) & (K Units)
Figure 9. Europe Dry Powder Inhaler Device Production (2021-2032) & (K Units)
Figure 10. China Dry Powder Inhaler Device Production (2021-2032) & (K Units)
Figure 11. Japan Dry Powder Inhaler Device Production (2021-2032) & (K Units)
Figure 12. Dry Powder Inhaler Device Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Dry Powder Inhaler Device Consumption (2021-2032) & (K Units)
Figure 15. World Dry Powder Inhaler Device Consumption Market Share by Region (2021-2032)
Figure 16. United States Dry Powder Inhaler Device Consumption (2021-2032) & (K Units)
Figure 17. China Dry Powder Inhaler Device Consumption (2021-2032) & (K Units)
Figure 18. Europe Dry Powder Inhaler Device Consumption (2021-2032) & (K Units)
Figure 19. Japan Dry Powder Inhaler Device Consumption (2021-2032) & (K Units)
Figure 20. South Korea Dry Powder Inhaler Device Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Dry Powder Inhaler Device Consumption (2021-2032) & (K Units)
Figure 22. India Dry Powder Inhaler Device Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Dry Powder Inhaler Device by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Dry Powder Inhaler Device Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Dry Powder Inhaler Device Markets in 2025
Figure 26. United States VS China: Dry Powder Inhaler Device Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Dry Powder Inhaler Device Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Dry Powder Inhaler Device Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Dry Powder Inhaler Device Production Market Share 2025
Figure 30. China Based Manufacturers Dry Powder Inhaler Device Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Dry Powder Inhaler Device Production Market Share 2025
Figure 32. World Dry Powder Inhaler Device Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Dry Powder Inhaler Device Production Value Market Share by Type in 2025
Figure 34. Single Dose
Figure 35. Multi Dose
Figure 36. World Dry Powder Inhaler Device Production Market Share by Type (2021-2032)
Figure 37. World Dry Powder Inhaler Device Production Value Market Share by Type (2021-2032)
Figure 38. World Dry Powder Inhaler Device Average Price by Type (2021-2032) & (USD/Unit)
Figure 39. World Dry Powder Inhaler Device Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 40. World Dry Powder Inhaler Device Production Value Market Share by Application in 2025
Figure 41. Asthma
Figure 42. COPD
Figure 43. Others
Figure 44. World Dry Powder Inhaler Device Production Market Share by Application (2021-2032)
Figure 45. World Dry Powder Inhaler Device Production Value Market Share by Application (2021-2032)
Figure 46. World Dry Powder Inhaler Device Average Price by Application (2021-2032) & (USD/Unit)
Figure 47. Dry Powder Inhaler Device Industry Chain
Figure 48. Dry Powder Inhaler Device Procurement Model
Figure 49. Dry Powder Inhaler Device Sales Model
Figure 50. Dry Powder Inhaler Device Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source


More Publications